Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
James H. Cavanaugh Insider Profile
4 Followers
James H. Cavanaugh, Director, Ten Percent Owner at Altimmune, holds 3.30M shares in Altimmune (Ticker: ALT), holds 262.05K shares in Leap Therapeutics (Ticker: LPTX). Most recently, James H. Cavanaugh ― shares of Altimmune on ― for an estimated value of ―.
James H. Cavanaugh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James H. Cavanaugh holds in companies
Most Profitable Insider Trade
The most profitable trade made by James H. Cavanaugh
James H. Cavanaugh's Trading History
Altimmune
―
Director, Ten Percent Owner
―
$27.20M
Leap Therapeutics
Nov 15, 2024
Director
Informative Buy
600.66
$762.57K
List of latest transactions for each holding click on a transaction to see James H. Cavanaugh's performance on stock
You May Also Like
James H. Cavanaugh insider profile FAQ
What is the percentage of profitable transactions made by James H. Cavanaugh?
The percentage of profitable transactions made by James H. Cavanaugh is ―.
What is the average return per transaction made by James H. Cavanaugh?
The average return per transaction made by James H. Cavanaugh is ―.
What stocks does James H. Cavanaugh hold?
James H. Cavanaugh holds: ALT, LPTX stocks.
What was James H. Cavanaugh’s latest transaction?
James H. Cavanaugh latest transaction was an Uninformative Buy of ―.
What was James H. Cavanaugh's most profitable transaction?
James H. Cavanaugh’s most profitable transaction was an Informative Buy of LPTX stock on November 15, 2024. The return on the trade was 6.20%.
What is James H. Cavanaugh's role in Altimmune?
James H. Cavanaugh's role in Altimmune is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.